|
|||||
|
|
Glycogen synthase kinase‐3 controls IL‐10 expression in CD4+ effector T‐cell subsets through epigenetic modification of the IL‐10 promoter |
|
| Authors: | Elaine V. Hill T. H. Sky Ng Bronwen R. Burton Charly M. Oakley Karim Malik David C. Wraith |
| Affiliation: | 1. School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK;2. Cancer Epigenetics Lab, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK |
| Abstract: | |
| Keywords: | CD4+ T cells Epigenetic Glycogen synthase kinase‐3 IL‐10 |